PRospective Evaluation of natriuretic peptide-based reFERral of patients with chronic heart failure in primary care (PREFER): a real-world study
Guardado en:
Autores principales: | Yigal M Pinto, Matthias Pauschinger, Finn Gustafsson, FD Richard Hobbs, Hector Bueno, Michael Obermeier, Benoit Lequeux, Rizwan I Hussain, Cristina Vitale, Philippe C Ferber |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a579d869b4364675bd5e49796723bfec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Natriuretic Peptides in Chronic Heart Failure
por: Hans-Peter Brunner-La Rocca, et al.
Publicado: (2019) -
The role of brain natriuretic peptide and NT- probrain natriuretic peptide in diagnostics of chronic heart failure and asymptomaticleft ventricular dysfunction in patients with type 2 diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2011) -
Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure
por: Hirotake Takahashi, et al.
Publicado: (2021) -
Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure
por: Francesca G. Bellagambi, et al.
Publicado: (2021) -
Focusing on Referral Rather than Selection for Advanced Heart Failure Therapies
por: Tonje Thorvaldsen, et al.
Publicado: (2019)